Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.49), $0.24 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.